3 unknown, 2 recruiting, 1 completed. 5 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 3, Completed 1, Recruiting 1 |
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Surgimab: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101 Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101 - Pancreas Adenocarcinoma | Phase 2 | Recruiting | Leiden University Medical Center | 20 | 2024-03-18 | 2024-04-04 |
| SGM-101 in Colorectal Brain Metastases. SGM-101 - Rectal Neoplasms, Rectum Cancer | Phase 2 | Unknown | Leiden University Medical Center | 10 | 2024-01-01 | 2024-05-09 |
| SGM-101 in Colorectal Lung Metastases SGM-101 - Colorectal Cancer, Metastatic Colon Cancer | Phase 2 | Unknown | Leiden University Medical Center | 10 | 2020-11-01 | 2021-02-03 |
| SGM-101 in Locally Advanced and Recurrent Rectal Cancer SGM-101 - Rectal Cancer, Recurrent Rectal Cancer | Phase 2 / Phase 3 | Unknown | Leiden University Medical Center | 203 | 2019-10-22 | 2020-11-24 |
| Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer SGM-101 - Colorectal Neoplasms | Phase 3 | Recruiting | Surgimab | 300 | 2019-06-17 | 2024-04-24 |
| Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas SGM-101 - Colon Cancer, Rectum Cancer | Phase 1 / Phase 2 | Completed | Surgimab | 75 | 2016-01-01 | 2019-07-18 |
Colorectal Neoplasms (4) · Rectal Neoplasms (3) · Colonic Neoplasms (2) · Neoplasms (2) · Brain Diseases (1) · Brain Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Pancreatic Neoplasms (1)
Netherlands (6) · Germany (1) · Italy (1) · United States (1)
Alex L. Vahrmeijer,, MD, PhD (1) · Alexander L Vahrmeijer, MD, PhD (1)
PMID 29361435, PMID 31960953, PMID 32416765, PMID 37552367
2023 (1)